Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Autoantibodies Prevalence and Their Related-diseases During Checkpoint Inhibitor Treatment

NCT04220034 is registered in ClinicalTrials.gov with CHU de Reims as lead sponsor.

NCT NCT04220034
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04220034 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Autoantibodies Prevalence and Their Related-diseases During Checkpoint Inhibitor Treatment
Lead sponsor
CHU de Reims
Phase
Observational
Overall status
Completed
Start date
January 15, 2020
Completion date
November 28, 2025
Enrollment
183 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

autoimmune adverse effects of anti-neoplasic drug